A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
NCT01802138
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Neuroblastoma
Interventions
BIOLOGICAL:
Activated T lymphocyte
Sponsor
Seoul National University Hospital